Analysis of Pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

被引：138
|
作者：
Tveit, A [1 ]
Grundtvig, M
Gundersen, T
Vanberg, P
Semb, AG
Holt, E
Gullestad, L
机构：
[1] Asker & Baerum Hosp, Dept Internal Med, N-1309 Rud, Norway
[2] Innlandel Lillehammer Hosp, Dept Internal Med, Lillehammer, Norway
[3] Sorlandet Hosp, Dept Internal Med, Arendal, Norway
[4] Aker Univ Hosp, Dept Internal Med, Oslo, Norway
[5] Diakonhjemmet Hosp, Dept Internal Med, Oslo, Norway
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 06期
关键词：
D O I：
10.1016/j.amjcard.2003.12.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To test the hypothesis that a statin could reduce the recurrence rate of atrial fibrillation after electrical cardioversion (EC), we performed an open, controlled multicenter study. Patients (n = 114) who had atrial fibrilation >48 hours and who were scheduled for EC were randomized to receive 40 mg of provastatin once daily for 3 weeks before and 6 weeks after EC or no drug in addition to standard therapy. Pravastatin did not reduce the recurrence rate of atrial fibrillation after EC. (C) 2004 by Excepta Medica, Inc.
引用
收藏
页码：780 / 782
页数：3
相关论文
共 50 条
  • [1] Atorvastatin did not prevent recurrence of atrial fibrillation in addition to antiarrhythmic therapy after electrical cardioversion
    Can, I.
    Demir, K.
    Ozdemir, K.
    Altunkeser, B. B.
    Tokac, M.
    Gok, H.
    EUROPEAN HEART JOURNAL, 2007, 28 : 809 - 809
  • [2] Time and frequency recurrence analysis of persistent atrial fibrillation after electrical cardioversion
    Alcaraz, Raul
    Rieta, Jose Joaquin
    PHYSIOLOGICAL MEASUREMENT, 2009, 30 (05) : 479 - 489
  • [3] Supraventricular ectopy and recurrence of atrial fibrillation after electrical cardioversion
    Chong, James J. H.
    Kumar, Saurabh
    Thomas, Liza
    Thomas, Stuart
    EUROPACE, 2006, 8 (05): : 341 - 344
  • [4] Markers of inflammation and recurrence of atrial fibrillation after electrical cardioversion
    Tveit, A.
    Grundvold, I.
    Seljeflot, I.
    Abdelnoor, M.
    Arnesen, H.
    Smith, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 43 - 43
  • [5] Factors influencing the recurrence of atrial fibrillation after electrical cardioversion
    Patriki, D.
    Frey, B.
    Binder, T.
    Maurer, G.
    Gyoengyoesi, M.
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S43 - S43
  • [6] Predicting recurrence of atrial fibrillation after electrical cardioversion: gauging atrial damage
    Siu, Chung-Wah
    Tse, Hung-Fat
    EUROPACE, 2010, 12 (06): : 764 - 765
  • [7] Analysis of heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion
    Vaiciulyte, R
    Losinskiene, L
    FRONTIERS IN CORONARY ARTERY DISEASE, 2003, : 305 - 307
  • [8] Dabigatran to reduce recurrence of atrial fibrillation after successful electrical cardioversion
    Obst, C.
    Roithinger, F. X.
    Fiedler, L.
    Schoenbauer, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S62 - S63
  • [9] Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion
    Garcia-Fernandez, Amaya
    Marin, Francisco
    Mainar, Luis
    Roldan, Vanessa
    Martinez, Juan G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (09): : 1299 - 1300
  • [10] Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion
    Vikman, S
    Mäkikallio, TH
    Yli-Mäyry, S
    Nurmi, M
    Airaksinen, KEJ
    Huikuri, HV
    ANNALS OF MEDICINE, 2003, 35 (01) : 36 - 42
12345